title: Dseq SCC25 treated with the FZD4-blocker FzDM1
design: SCC25 low passage cell line were treated for 5 consecutive days with FzM1 (#HY-116553; MCE- treatment group). After treatment, the cells were fixed for follow-up analyses. Total RNA was extracted and used for RNA sequencing library production or validated through RT-PCR.